Open AccessSerum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques
Author(s) -
Berit Velstra,
M. A. A. Vonk,
Bert A. Bonsing,
Bart Mertens,
Simone Nicolardi,
A. Huijbers,
Hans F. A. Vasen,
André M. Deelder,
Wilma E. Mesker,
Yuri E. M. van der Burgt,
Rob A.�E.�M. Tollenaar
Publication year - 2014
Publication title -
journal of cancer research and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.338
H-Index - 94
eISSN - 1432-1335
pISSN - 0171-5216
DOI - 10.1007/s00432-014-1812-2
Subject(s) - pancreatic cancer , mass spectrometry , hematology , ca19 9 , peptide , medicine , cancer , oncology , chemistry , chromatography , biochemistry
The detection of pancreatic tumors lacks a sensitive and specific diagnostic tool. Mass spectrometry (MS)-based profiling of serum proteins is a promising approach for discovery of new clinical biomarkers or biomarker signatures.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom